NITI-S PYLORIC & DUODENAL COVERED STENT DCT2010BP

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a distributor report with the FDA on 2019-04-26 for NITI-S PYLORIC & DUODENAL COVERED STENT DCT2010BP manufactured by Taewoong Medical Co.,ltd..

Event Text Entries

[143259469] It was reported that, 2 months after placing the stent, the reocclusion occurred, and it looks to be in-growth by seeing the images through the scope. Also, the stent had the other hole than the stenosis part. Through the attached photo, it is confirmed that two cover holes were observed and in/over growth has occurred on the stent body part, resulted in reocclusion. It was confirmed from the device history record that device had been manufactured with no significant issue and passed all the inspections successfully. Duodenum structure where stent was implanted is curvy. It is possible that the stent can be pressed by patient's lesion. However, it is hard to identify the exact root cause since it is hard to reconstruct the situation at the time of procedure. It is hard to identify the root cause because the suspected device was not returned. However, based on the two cover holes near the patient's lesion and reocclusion, it is assumed that the cover was weaken due to the patient lesion's peristalses and foreign substance such as foods, body fluids and so on, resulted in occurring the hole and/or the damage. Also, tumor in/over growth has occurred on the damaging part, resulted in reocclusion. It is stated on user manual as follows. 6. Potential complications potential complications associated with the use of niti-s & comvi stent may include, but are not limited to: tumor ingrowth, tumor overgrowth, stent occlusion. This suspected device is not registered in the us but we will continuously monitor the same or similar customer complaints through accurate analyses.
Patient Sequence No: 1, Text Type: N, H10


[143259470] On (b)(6) 2018: niti-s pyloric comvi stent was placed. On (b)(6) 2019: for the reocclusion of the stent placed in (b)(6) 2018 above, another niti-s pyloric comvistent was placed. Before the procedure, the physician expected that the covered part was pushed in due to the reocclusion, however, it looks to be in-growth by seeing the images through the scope. Over-growth in distal side was also considered but it was well extended. The stent placed first had the other hole than the stenosis part. It is expected that the durability of the cover got weak because the cell was larger with the cover itself against the stenosis. Another stent (niti-s) was used to finish the procedure.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3003902943-2019-00011
MDR Report Key8553513
Report SourceDISTRIBUTOR
Date Received2019-04-26
Date of Report2019-03-29
Date of Event2019-02-25
Date Mfgr Received2019-03-29
Device Manufacturer Date2018-09-03
Date Added to Maude2019-04-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. LEE
Manufacturer Street14, GOJEONG-RO WOLGOT-MYEON
Manufacturer CityGIMPO-SI, GYEONGGI-DO 10022
Manufacturer CountryKS
Manufacturer Postal10022
Manufacturer G1TAEWOONG MEDICAL CO.,LTD.
Manufacturer Street14, GOJEONG-RO WOLGOT-MYEON
Manufacturer CityGIMPO-SI, GYEONGGI-DO 10022
Manufacturer CountryKS
Manufacturer Postal Code10022
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNITI-S PYLORIC & DUODENAL COVERED STENT
Generic NamePYLORIC & DUODENAL STENT
Product CodeMUM
Date Received2019-04-26
Model NumberDCT2010BP
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerTAEWOONG MEDICAL CO.,LTD.
Manufacturer Address14, GOJEONG-RO WOLGOT-MYEON GIMPO-SI, GYEONGGI-DO 10022 KS 10022


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2019-04-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.